(Reuters) - Allergan Plc said on Thursday former Abbott Laboratories executive Thomas Freyman will join its board, a week after two of its shareholders criticized the drugmaker's acquisition strategy and board composition.


20


Reuters

18 Related Articles from 2018-06-14